Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients

To investigate the effects of antihypertensive treatment with the angiotensin-converting enzyme (ACE) inhibitor lisinopril on insulin sensitivity and related metabolic variables, the insulin sensitivity index (SI), determined with the Minimal Model Method of Bergman, fasting plasma insulin and gluco...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical pharmacology 1995-11, Vol.49 (1-2), p.21-26
Hauptverfasser:	THÜRIG, C, BÖHLEN, L, SCHNEIDER, M, DE COURTEN, M, SHAW, S. G, RIESEN, W, WEIDMANN, P
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Angiotensin-Converting Enzyme Inhibitors - adverse effects Angiotensin-Converting Enzyme Inhibitors - pharmacology Antihypertensive agents Biological and medical sciences Blood Glucose - drug effects Blood Glucose - metabolism Blood Pressure - drug effects Cardiovascular system Cholesterol - blood Cross-Over Studies Double-Blind Method Female Humans Hypertension - blood Hypertension - drug therapy Insulin - blood Insulin Resistance Lipoproteins - blood Lisinopril - adverse effects Lisinopril - pharmacology Male Medical sciences Middle Aged Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!